Centrifuge Launched for Blood Banking and Bioprocessing
By LabMedica International staff writers Posted on 07 Dec 2010 |

Image: The Sorvall RC 12BP Plus centrifuge (photo courtesy Thermo Fisher Scientific).
A high-throughput floor-standing centrifuge was introduced for blood banking and bioprocessing applications.
The centrifuge's run-to-run reproducibility is ensured by the Accumulated Centrifugal Effect (ACE) function, which automatically compensates for any variations in acceleration due to full or partial rotor loading. Precise control of acceleration and deceleration rates ensures that sample integrity is retained, even during delicate low-speed pelleting applications.
Thermo Fisher Scientific (Waltham, MA, USA) introduced the new large capacity Sorvall RC 12BP Plus centrifuge. With a maximum capacity of 12 L, the centrifuge can process up to 12 blood bag systems (up to 500 mL) or six 2,000-mL Thermo Scientific Nalgene bio-bottles.
The Sorvall RC 12BP Plus centrifuge can be optimized through the incorporation of the Thermo Scientific H-12000 large-capacity swinging bucket rotors. Capable of spinning 2 L Nalgene polypropylene bottles, which have a graduated wide mouth for simple decanting, resuspensions and pellet removal, these rotors provide excellent capacities.
The optional Thermo Scientific Centri-Log data collection software is a paperless method of increasing quality control, process traceability, and component tracking. Compliance with Good Manufacturing Practice (cGMP) guidelines ensures sample security and integrity.
Set-up and operation are facilitated by an interface, which incorporates a 15-program memory with one-touch recall of commonly used protocols. In addition, a security key prevents unauthorized access.
Related Links:
Thermo Fisher Scientific
The centrifuge's run-to-run reproducibility is ensured by the Accumulated Centrifugal Effect (ACE) function, which automatically compensates for any variations in acceleration due to full or partial rotor loading. Precise control of acceleration and deceleration rates ensures that sample integrity is retained, even during delicate low-speed pelleting applications.
Thermo Fisher Scientific (Waltham, MA, USA) introduced the new large capacity Sorvall RC 12BP Plus centrifuge. With a maximum capacity of 12 L, the centrifuge can process up to 12 blood bag systems (up to 500 mL) or six 2,000-mL Thermo Scientific Nalgene bio-bottles.
The Sorvall RC 12BP Plus centrifuge can be optimized through the incorporation of the Thermo Scientific H-12000 large-capacity swinging bucket rotors. Capable of spinning 2 L Nalgene polypropylene bottles, which have a graduated wide mouth for simple decanting, resuspensions and pellet removal, these rotors provide excellent capacities.
The optional Thermo Scientific Centri-Log data collection software is a paperless method of increasing quality control, process traceability, and component tracking. Compliance with Good Manufacturing Practice (cGMP) guidelines ensures sample security and integrity.
Set-up and operation are facilitated by an interface, which incorporates a 15-program memory with one-touch recall of commonly used protocols. In addition, a security key prevents unauthorized access.
Related Links:
Thermo Fisher Scientific
Latest Technology News
- Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples
- Pain-On-A-Chip Microfluidic Device Determines Types of Chronic Pain from Blood Samples
- Innovative, Label-Free Ratiometric Fluorosensor Enables More Sensitive Viral RNA Detection
- Smartphones Could Diagnose Diseases Using Infrared Scans
- Novel Sensor Technology to Enable Early Diagnoses of Metabolic and Cardiovascular Disorders
- 3D Printing Breakthrough Enables Large Scale Development of Tiny Microfluidic Devices
- POC Paper-Based Sensor Platform to Transform Cardiac Diagnostics
- Study Explores Impact of POC Testing on Future of Diagnostics
- Low-Cost, Fast Response Sensor Enables Early and Accurate Detection of Lung Cancer
- Nanotechnology For Cervical Cancer Diagnosis Could Replace Invasive Pap Smears
- Lab-On-Chip Platform to Expedite Cancer Diagnoses
- Biosensing Platform Simultaneously Detects Vitamin C and SARS-CoV-2
- New Lens Method Analyzes Tears for Early Disease Detection
- FET-Based Sensors Pave Way for Portable Diagnostic Devices Capable of Detecting Multiple Diseases
- Paper-Based Biosensor System to Detect Glucose Using Sweat Could Revolutionize Diabetes Management
- First AI-Powered Blood Test Identifies Patients in Earliest Stage of Breast Cancer
Channels
Clinical Chemistry
view channel
‘Brilliantly Luminous’ Nanoscale Chemical Tool to Improve Disease Detection
Thousands of commercially available glowing molecules known as fluorophores are commonly used in medical imaging, disease detection, biomarker tagging, and chemical analysis. They are also integral in... Read more
Low-Cost Portable Screening Test to Transform Kidney Disease Detection
Millions of individuals suffer from kidney disease, which often remains undiagnosed until it has reached a critical stage. This silent epidemic not only diminishes the quality of life for those affected... Read more
New Method Uses Pulsed Infrared Light to Find Cancer's 'Fingerprints' In Blood Plasma
Cancer diagnoses have traditionally relied on invasive or time-consuming procedures like tissue biopsies. Now, new research published in ACS Central Science introduces a method that utilizes pulsed infrared... Read moreMolecular Diagnostics
view channel
Cheap Cell-Free DNA Based Test Accurately Predicts Preterm Birth
Preterm birth (PTB) occurs in around 11% of all births globally, leading to considerable morbidity and mortality for both mothers and their newborns. Identifying pregnancies at risk of PTB early in gestation... Read more
RNA Blood Test Detects Cancers and Resistance to Treatment
A newly developed blood test offers the ability to detect cancer, understand how cancer resists treatments, and assess tissue damage from non-cancerous conditions. This innovative test, created by researchers... Read moreHematology
view channel
New Scoring System Predicts Risk of Developing Cancer from Common Blood Disorder
Clonal cytopenia of undetermined significance (CCUS) is a blood disorder commonly found in older adults, characterized by mutations in blood cells and a low blood count, but without any obvious cause or... Read more
Non-Invasive Prenatal Test for Fetal RhD Status Demonstrates 100% Accuracy
In the United States, approximately 15% of pregnant individuals are RhD-negative. However, in about 40% of these cases, the fetus is also RhD-negative, making the administration of RhoGAM unnecessary.... Read moreImmunology
view channel
Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer
Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more
Machine Learning-Enabled Blood Test Predicts Immunotherapy Response in Lymphoma Patients
Chimeric antigen receptor (CAR) T-cell therapy has emerged as one of the most promising recent developments in the treatment of blood cancers. However, over half of non-Hodgkin lymphoma (NHL) patients... Read moreMicrobiology
view channel
Handheld Device Delivers Low-Cost TB Results in Less Than One Hour
Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more
New AI-Based Method Improves Diagnosis of Drug-Resistant Infections
Drug-resistant infections, particularly those caused by deadly bacteria like tuberculosis and staphylococcus, are rapidly emerging as a global health emergency. These infections are more difficult to treat,... Read more
Breakthrough Diagnostic Technology Identifies Bacterial Infections with Almost 100% Accuracy within Three Hours
Rapid and precise identification of pathogenic microbes in patient samples is essential for the effective treatment of acute infectious diseases, such as sepsis. The fluorescence in situ hybridization... Read morePathology
view channel
Rapid, Ultra-Sensitive, PCR-Free Detection Method Makes Genetic Analysis More Accessible
Genetic testing has been an important method for detecting infectious diseases, diagnosing early-stage cancer, ensuring food safety, and analyzing environmental DNA. For a long time, polymerase chain reaction... Read more
Spit Test More Accurate at Identifying Future Prostate Cancer Risk
Currently, blood tests that measure the level of a protein called prostate-specific antigen (PSA) are commonly used to identify men at higher risk for prostate cancer. This test is typically used based... Read more
DNA Nanotechnology Boosts Sensitivity of Test Strips
Since the Covid-19 pandemic, most people have become familiar with paper-based rapid test strips, also known as lateral flow immunoassays (LFIAs). These tests are used to quickly detect biomarkers that... Read more
Novel UV and Machine Learning-Aided Method Detects Microbial Contamination in Cell Cultures
Cell therapy holds great potential in treating diseases such as cancers, inflammatory conditions, and chronic degenerative disorders by manipulating or replacing cells to restore function or combat disease.... Read moreIndustry
view channel
Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions
Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Grifols and Tecan’s IBL Collaborate on Advanced Biomarker Panels
Grifols (Barcelona, Spain), one of the world’s leading producers of plasma-derived medicines and innovative diagnostic solutions, is expanding its offer in clinical diagnostics through a strategic partnership... Read more